Home » Newsletters » BioWorld Science

BioWorld Science

July 8, 2003

View Archived Issues

Alemtuzumab reported to increase clinical response and remission in refractory CLL

Emfilermin reported to improve implantation and pregnancy rates in women with RIF

Clinical trials assess the benefits and safety of metformin in women with PCOS

Buspirone in hot flashes in menopausal women

Safer antiarrhythmic agents newly developed at ARYx

Novel vitamin D analogues with utility in dermatological disorders designed at Galderma

New EGFR/HER2 kinase inhibitors under study at Wyeth

Ultrafine patent covers new agents with antimalarial and antitumor activity

BMS researchers present new compounds with factor VIIa/IMPDH-inhibitory activity

Filings announced for new rapid-acting insulin analogue

Erbitux submitted to E.U. and Swiss regulatory authorities

Roche licenses rights to market Avastin outside the U.S.

FDA decides against approval for Fortigel

ViroPharma advances towards the development of drug for smallpox

New indication cleared in Europe for Norditropin

Phase II trial of GTI-2040 in AML cleared by FDA

Enrollment imminent in phase III trial of Aryplase in MPS VI patients

Pravastatin improves cardiovascular risk in women with coronary heart disease

Good tolerability profile reported for IMC-1C11 in patients with metastatic colorectal cancer

GSK-3 inhibitors and their use claimed by Vertex

Promising clinical results for Mologen's dSLIM compounds in cancer patients

Antiviral efficacy of NM-283 shown in HCV-infected chimpanzees

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 23, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for April 21, 2026
Psychedelic space expanding on Trump’s EO
BioWorld
Timothy Leary is dead, but he could be on the outside looking in with a smile on his face as U.S. President Donald Trump’s latest executive order (EO) fuels a...
A free gene therapy? Regeneron’s Otarmeni approved for hearing loss
BioWorld
Children and adults with a type of congenital hearing loss now have a free treatment option, with the U.S. FDA’s accelerated approval of Regeneron Pharmaceuticals...
At AACR: Epigenetic fingerprints in metastases track tumor origin
BioWorld
When a tumor migrates and colonizes another tissue or organ, it can be identified as a metastasis, but its origin is not always clear. Now, a study based on...